Press Releases Glaukos Corporation

Equities

GKOS

US3773221029

Market Closed - Nyse Other stock markets 04:00:02 2024-04-29 pm EDT			5-day change	1st Jan Change
97.2 ^USD	-2.29%		-3.86%	+22.28%

Apr. 11	Mizuho Securities Adjusts Price Target on Glaukos to $100 From $85, Maintains Neutral Rating	MT
Apr. 11	Glaukos Insider Sold Shares Worth $6,008,359, According to a Recent SEC Filing	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Glaukos Announces the Release of its 2023 Sustainability Report	Apr. 16	BU
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1	Apr. 10	BU
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)	Apr. 03	BU
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting	Apr. 01	BU
Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial, Demonstrating Industry-Leading Accuracy and Innovation in Visual Field Testing for Virtual Reality Perimetry	Mar. 26	AQ
Celanese Announces Commercial Launch of Glaukos' iDose TR (Travoprost Intracameral Implant) using Celanese's VitalDose Ethylene Vinyl Acetate (EVA)	Mar. 01	AQ
Glaukos : Q4 2023 Earnings Transcript	Feb. 21	PU
Glaukos: Q4 Earnings Snapshot	Feb. 21	AQ
Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results	Feb. 21	BU
Glaukos : Q4 2023 Quarterly Summary	Feb. 20	PU
Glaukos : Q4 2023 GAAP to Non-GAAP Recs	Feb. 19	PU
Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21	Jan. 31	BU
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance	Jan. 09	BU
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference	Dec. 20	BU
Glaukos Announces FDA Approval of iDoseTR	Dec. 15	AQ
Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)	Dec. 14	BU
Glaukos Announces Participation in Stifel Healthcare Conference	Nov. 07	BU
Glaukos: Q3 Earnings Snapshot	Nov. 01	AQ
Glaukos Announces Third Quarter 2023 Financial Results	Nov. 01	BU
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting	23-10-31	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Glaukos Corporation

Equities

GKOS

US3773221029

Press Releases

Filters